Indian Drugs And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 120.00 Cr
as on 19-05-2024
- Paid Up Capital ₹ 116.88 Cr
as on 19-05-2024
- Company Age 63 Year, 8 Months
- Last Filing with ROC 31 Mar 2015
- Open Charges ₹ 9.00 Cr
as on 19-05-2024
- Revenue 6.53%
(FY 2015)
- Profit 4.59%
(FY 2015)
- Ebitda 34.77%
(FY 2015)
- Net Worth -2.46%
(FY 2015)
- Total Assets 7.64%
(FY 2015)
About Indian Drugs And Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2015. It's a company limited by shares with an authorized capital of Rs 120.00 Cr and a paid-up capital of Rs 116.88 Cr.
The company currently has active open charges totaling ₹9.00 Cr.
Sudhansh Pant and Manharbhai Zala serve as directors at the Company.
- CIN/LLPIN
U24231HR1961GOI003418
- Company No.
003418
- Company Classification
Private Limited Union Government Company
- Incorporation Date
05 Apr 1961
- Date of AGM
28 Aug 2015
- Date of Balance Sheet
31 Mar 2015
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurgaon, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Indian Drugs And Pharmaceuticals Limited offer?
Indian Drugs And Pharmaceuticals Limited offers a wide range of products and services, including Common Disease Medicines, Antiseptic Mouthwashes, Healthcare Products & Aids, Health Drinks, Router, Cables & Networking Devices, Web Server, Nutraceuticals, Food Supplement, Pharmaceutical Tablets, Nutraceuticals & Dietary Supplements.
Who are the key members and board of directors at Indian Drugs And Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudhansh Pant  | Managing Director | 28-Jan-2015 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manharbhai Zala | Director | 17-Jun-2016 | Current |
Financial Performance and Corporate Structure Insights of Indian Drugs And Pharmaceuticals.
Indian Drugs And Pharmaceuticals Limited, for the financial year ended 2015, experienced modest growth in revenue, with a 6.53% increase. The company also saw a slight improvement in profitability, with a 4.59% increase in profit. The company's net worth dipped by a decrease of 2.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indian Drugs And Pharmaceuticals?
In 2015, Indian Drugs And Pharmaceuticals had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 27 May 2008 | ₹9.00 Cr | Open |
How Many Employees Work at Indian Drugs And Pharmaceuticals?
Indian Drugs And Pharmaceuticals has a workforce of 27 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indian Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indian Drugs And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
